Consonance Capital Management LP 13D and 13G filings for Assembly Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 2:45 pm Sale | 2021-12-31 | 13G | Assembly Biosciences, Inc. ASMB | Consonance Capital Management LP | 0 0.000% | -164,156 (Position Closed) | Filing |
| 2021-02-17 3:07 pm Sale | 2020-12-31 | 13G | Assembly Biosciences, Inc. ASMB | Consonance Capital Management LP | 164,156 5.970% | -340,719 (-67.49%) | Filing |
| 2021-02-16 4:18 pm Purchase | 2020-12-31 | 13G | Assembly Biosciences, Inc. ASMB | Consonance Capital Management LP | 504,875 9.990% | 340,719 (+207.56%) | Filing |
| 2021-02-16 2:38 pm Purchase | 2020-12-31 | 13G | Assembly Biosciences, Inc. ASMB | Consonance Capital Management LP | 164,156 5.970% | 7,623 (+4.87%) | Filing |
| 2020-02-14 12:37 pm Purchase | 2019-12-31 | 13G | Assembly Biosciences, Inc. ASMB | Consonance Capital Management LP | 156,533 7.210% | 156,533 (New Position) | Filing |